HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic factors in cardiac hypertrophy.

Abstract
Cardiac hypertrophy is an adaptive response to any cardiac insult or stress that increases hemodynamic load. Cardiac hypertrophy can exist in a state of compensation or progress to a decompensated state (i.e., heart failure) over time. It has been established through transgenic overexpression and gene ablation studies that multiple signaling pathways are involved in the induction of hypertrophy as well as its decompensation. This article reviews the role of G alpha q in the development of pressure overload hypertrophy and discusses the relationships between G alpha q and beta-adrenergic receptors, RGS proteins, and the proapoptotic factor, Nix/Bnip3L.
AuthorsGerald W Dorn 2nd, Harvey S Hahn
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 1015 Pg. 225-37 (May 2004) ISSN: 0077-8923 [Print] United States
PMID15201163 (Publication Type: Journal Article, Review)
Chemical References
  • Protein Kinase C
  • GTP-Binding Protein alpha Subunits, Gq-G11
Topics
  • Apoptosis (genetics)
  • Cardiomegaly (genetics, pathology, physiopathology)
  • GTP-Binding Protein alpha Subunits, Gq-G11 (physiology)
  • Protein Kinase C (metabolism)
  • Signal Transduction (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: